Does Anavex's Alzheimer's Drug Actually Confer Benefit?

Group 1 - A new drug has been reported to slow cognitive decline in Alzheimer's patients by 36%, and by nearly 50% for a specific subgroup of patients [1] - The Biden administration's solar import duty policy is viewed as a significant barrier to the growth of clean energy [1] - The author has written extensively on various clean energy companies, including Canadian Solar and JinkoSolar, indicating a focus on the clean energy sector [1] Group 2 - The author has a beneficial long position in AVXL shares, reflecting confidence in the company's prospects [2] - The author previously held a long position in BIIB but no longer does, indicating a shift in investment strategy [2]